 CDK1 activity and protein abundance

CDK1 activity and protein abundance are different observables. A total-CDK1 Western blot estimates protein amount under its calibration and loading assumptions. A phosphosite-specific Western blot asks about a particular CDK1 phosphorylation state. A histone H1 kinase assay asks how much substrate modification occurs under specified assay conditions. Any conversion between them needs a model and suitable controls.

An original counting example stipulates $100$ CDK1 molecules, with $60$ bound to cyclin B in each of two hypothetical samples. In sample A, $10$ bound molecules are activity-permissive and $50$ are inhibited; in sample B, $40$ are activity-permissive and $20$ are inhibited. The other $40$ are unbound in both samples. Total CDK1 and bound CDK1 agree, but activity-permissive counts differ fourfold. These are invented counts for bookkeeping, not measured biological populations.

If each activity-permissive molecule contributes the same reaction rate, substrate and ATP remain available, and the assay stays linear in time, a simple illustrative readout isHere $R$ is the recorded signal, $R_0$ is a matched blank signal, $N_{\mathrm{active}}$ is the activity-permissive count, $t$ the reaction interval, and $\alpha$ a common signal contribution per active molecule per unit time. The corrected signals in the stipulated samples have ratio $40/10=4$, although their total protein amounts agree. This is an assay accounting assumption, not an ordinary differential equation for the cell cycle. The no-added-cyclin B baseline in the inspected experiment can itself contain catalytic activity; it need not equal an enzyme-free blank $R_0$.

Substrate depletion, differing inhibitory conditions or a saturated detector can break the simple proportionality. Comparing samples therefore requires matched reaction intervals, substrate supply, loading and detector response, rather than assuming that brighter histone H1 labeling automatically means more total CDK1.